anti-P2X7 receptor monoclonal antibody (MedImmune)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-P2X7 receptor monoclonal antibody (MedImmune)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionP2X purinoceptor 7 antagonists
TargetsP2X purinoceptor 7
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedimmune Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedimmune Llc
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A